Ethical issues associated with conducting genetic family studies of complex disease

被引:16
作者
Arar, NH
Hazuda, H
Steinbach, R
Arar, MY
Abboud, HE
机构
[1] Univ Texas, Ctr Hlth Sci, Dept Med Nephrol, Div Nephrol, San Antonio, TX 78229 USA
[2] Audie L Murphy Mem Vet Adm Med Ctr, Div Nephrol, Dept Pediat, San Antonio, TX 78284 USA
关键词
genetic family studies; ethical issues; Contextual Assessment Approach; subject-centered approach;
D O I
10.1016/j.annepidem.2004.09.010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE: To examine subjects' recognition of the risks and ethical issues associated with enrollment in genetic family studies (GFS) and explore how this recognition affects their informed and voluntary participation. METHODS: A cross-sectional study design including both quantitative and qualitative data was employed. Structured interviews using the Contextual Assessment Approach Questionnaire (CAA-Q) were conducted with 246 Mexican American (MA) participants. To gain in-depth understanding of questionnaire responses, semi-structured interviews with 30 participants were conducted. All participants were interviewed before their enrollment in the Family Investigation of Nephropathy and Diabetes (FIND). RESULTS: Subjects' average age was 56 years; 62% were females. Seventy-eight percent of participants were not formally educated beyond high school and 72% reported an annual household income of <= $20,000. Eighty-five percent agreed to provide researchers with information on relatives' ages, gender, and education. Sixty-five percent of participants were willing to provide identifiable information such as names, addresses, and phone numbers of relatives. Sixty-three percent of participants indicated that there were direct benefits (i.e., supporting research) to disclosing relatives' information. Seventy-six percent stated that there were no risks associated with participation in GFS (e.g., discrimination or confidentiality of genetic information) compared with 10% who said that there were such risks. While discussing potential risks, subjects did not consider these to influence their decision to participate. CONCLUSIONS: Subjects enrolled in GFS did not recognize and tended to underestimate the social and cultural risks associated with their participation in GFS. If subjects do not fully comprehend the risks, this raises questions concerning their ability to provide informed consent and to voluntarily participate. We propose a subject-centered approach that views enrollment as an active process in which subjects and recruiters give and receive information on risks and ethical issues related to participation, which enhances protection of the rights and welfare of subjects participating in GFS.
引用
收藏
页码:712 / 719
页数:8
相关论文
共 46 条
[21]  
COOKDEEGAN R, 2001, J CONTIN EDUC HEALTH, V24, P224
[22]   Communal discourse as a supplement to informed consent for genetic research [J].
Foster, MW ;
Eisenbraun, AJ ;
Carter, TH .
NATURE GENETICS, 1997, 17 (03) :277-279
[23]   Naming names in human genetic variation research [J].
Foster, MW ;
Freeman, WL .
GENOME RESEARCH, 1998, 8 (08) :755-757
[24]   A model agreement for genetic research in socially identifiable populations [J].
Foster, MW ;
Bernsten, D ;
Carter, TH .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (03) :696-702
[25]   Genetic testing for susceptibility to adult-onset cancer - The process and content of informed consent [J].
Geller, G ;
Botkin, JR ;
Green, MJ ;
Press, N ;
Biesecker, B ;
Wilfond, B ;
Grana, G ;
Daly, MB ;
Schneider, K ;
Kahn, MJE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1467-1474
[26]   Primer on medical genomics part XIII: Ethical and regulatory issues [J].
Hook, CC ;
DiMagno, EP ;
Tefferi, A .
MAYO CLINIC PROCEEDINGS, 2004, 79 (05) :645-650
[27]  
HUBBARD R, 1994, GENES HUMAN SELF KNO, P196
[28]   GENETIC DISCRIMINATION AND HEALTH-INSURANCE - AN URGENT NEED FOR REFORM [J].
HUDSON, KL ;
ROTHENBERG, KH ;
ANDREWS, LB ;
KAHN, MJE ;
COLLINS, FS .
SCIENCE, 1995, 270 (5235) :391-393
[29]   Sociocultural influences on participation in genetic risk assessment and testing among African American women [J].
Hughes, C ;
Fasaye, GA ;
LaSalle, VH ;
Finch, C .
PATIENT EDUCATION AND COUNSELING, 2003, 51 (02) :107-114
[30]   Rewriting the "points to consider": The ethical impact of guidance document language [J].
King, NMP .
HUMAN GENE THERAPY, 1999, 10 (01) :133-139